SFDA registers Jascayd for idiopathic pulmonary fibrosis
A new medicine for a rare lung disease has been cleared for use in Saudi Arabia. The Saudi Food and Drug Authority has registered Jascayd, whose active ingredient is nerandomilast, for adults with…